Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-09-17 Duliege Anne-Marie EVP & Chief Medical Officer Sale −37,500 $3.50 $131K 0
2018-09-17 Duliege Anne-Marie EVP & Chief Medical Officer Exercise or conversion · Employe Stock Option (right to buy) −115,500 268,000
2018-09-17 Duliege Anne-Marie EVP & Chief Medical Officer Exercise or conversion · Employee Stock Option (right to buy) −37,500 112,500
2018-09-11 Mayer Eldon C. III EVP & Chief Commercial Officer Purchase +50,000 $3.23 $161K 215,000
2018-09-10 Mayer Eldon C. III EVP & Chief Commercial Officer Purchase +50,000 $3.28 $164K 165,000
2018-09-04 Duliege Anne-Marie EVP & Chief Medical Officer Exercise or conversion +16,500 $2.54 $42K 16,500
2018-09-04 Duliege Anne-Marie EVP & Chief Medical Officer Sale −16,500 $3.51 $58K 0
2018-09-04 Duliege Anne-Marie EVP & Chief Medical Officer Exercise or conversion · Employe Stock Option (right to buy) −16,500 383,500
2018-08-23 Mayer Eldon C. III EVP & Chief Commercial Officer Purchase +100,000 $2.82 $282K 115,000
2018-08-17 RODRIGUEZ RAUL R CEO, President Purchase +114,000 $2.63 $300K 173,519

Page 16 of 16 · 310 trades